Chocolate milk, Will Smith, and the concussion study nobody could read

Michael Walter | | Health Imaging | Neuroimaging

When the movie “Concussion” starring Will Smith hit theaters, a chocolate milk company wanted to use the opportunity to promote its drink’s ability to help young athletes recover from concussions, according to a new report by the Associated Press.

The AP points out that this is the continuation of an ongoing saga involving the company, Fifth Quarter Milk.

Back in December 2015, a press release came out promoting the milk’s effectiveness at “improving the cognitive and motor functions of high school football players, even after they suffered concussions.” But the actual study was never released to the public.

Click below for the full scoop from the AP, which was shared by ABC News: 

Chocolate Milk Maker Wanted Study Touted With "Concussion"

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Experts update AUC for amyloid, tau PET imaging for first time in more than a decade
Infamous kidnapping survivor shares brain scan findings detailing the impact of her trauma
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care
How gaming addiction affects brain activity, according to new MRI data
How opioid use disorder affects brain size and function
Radiomics model links brain MRI features with neuropsychological changes in Crohn's disease

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.